JP2008538494A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538494A5
JP2008538494A5 JP2008505606A JP2008505606A JP2008538494A5 JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5 JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5
Authority
JP
Japan
Prior art keywords
xmrv
acid sequence
individual
seq
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008505606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538494A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/013167 external-priority patent/WO2006110589A2/en
Publication of JP2008538494A publication Critical patent/JP2008538494A/ja
Publication of JP2008538494A5 publication Critical patent/JP2008538494A5/ja
Pending legal-status Critical Current

Links

JP2008505606A 2005-04-07 2006-04-07 癌と関連するガンマレトロウイルス Pending JP2008538494A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66947305P 2005-04-07 2005-04-07
US75180905P 2005-12-19 2005-12-19
PCT/US2006/013167 WO2006110589A2 (en) 2005-04-07 2006-04-07 Gammaretrovirus associated with cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012217415A Division JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Publications (2)

Publication Number Publication Date
JP2008538494A JP2008538494A (ja) 2008-10-30
JP2008538494A5 true JP2008538494A5 (https=) 2009-05-28

Family

ID=37024999

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008505606A Pending JP2008538494A (ja) 2005-04-07 2006-04-07 癌と関連するガンマレトロウイルス
JP2012217415A Pending JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012217415A Pending JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Country Status (8)

Country Link
US (2) US8263085B2 (https=)
EP (1) EP1882032A2 (https=)
JP (2) JP2008538494A (https=)
AU (1) AU2006235266B2 (https=)
CA (1) CA2603863A1 (https=)
MX (1) MX2007012361A (https=)
NZ (1) NZ562221A (https=)
WO (1) WO2006110589A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2603863A1 (en) 2005-04-07 2006-10-19 The Cleveland Clinic Foundation Gammaretrovirus associated with cancer
DK2310023T3 (en) * 2008-07-31 2016-12-12 Sigma Tau Ind Farmaceuti COMPOSITION, WHICH INCLUDES green tea AND EXTRACT OF POMEGRANATE FOR USE IN PREVENTING OR REDUCING THE PROGRESSION OF PROSTATE CANCER
EP2382326A2 (en) 2008-12-23 2011-11-02 The Cleveland Clinic Foundation Method for detection of xmrv
JP5755569B2 (ja) * 2009-02-25 2015-07-29 セファイド 肺癌を検出する方法
WO2010132886A1 (en) * 2009-05-15 2010-11-18 The University Of Utah Research Foundation Compositions and methods relating to xmrv-related diseases and conditions
WO2010148323A2 (en) * 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
JP2012532190A (ja) * 2009-06-30 2012-12-13 アボット ラボラトリーズ Ｘｍｒｖ感染のマーカーとその使用
WO2011041350A2 (en) * 2009-10-02 2011-04-07 Emory University Xenotropic mulv-related virus (xmrv) compositions and methods of use
WO2011091395A1 (en) * 2010-01-25 2011-07-28 Functional Genetics, Inc. Antibodies for diagnosis and therapeutic treatment of prostate cancer
WO2011092199A1 (en) 2010-01-26 2011-08-04 Institut Gustave Roussy Mutated xmrv env proteins in the immunosuppressive domain
US20110311484A1 (en) * 2010-04-06 2011-12-22 Whittemore Peterson Institute For Neuro-Immune Disease Strains of xenotropic murine leukemia-related virus and methods for detection thereof
EP2913402B1 (en) * 2010-07-16 2017-10-18 Tocagen Inc. Retrovirus detection
US20120058462A1 (en) * 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
US20120058461A1 (en) * 2010-08-18 2012-03-08 Abbott Laboratories Molecular detection of xmrv infection
EP2611932A2 (en) * 2010-08-30 2013-07-10 Gen-Probe Incorporated Compositions, methods and reaction mixtures for the detection of xenotropic murine leukemia virus-related virus
US9107892B2 (en) * 2010-10-28 2015-08-18 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of a novel retrovirus in patients with benign prostatic hyperplasia
GB201019043D0 (en) 2010-11-10 2010-12-22 Protea Biopharma N V Use of 2',5'-oligoadenylate derivative compounds
JP2014513521A (ja) 2011-01-26 2014-06-05 セファイド 肺癌を検出する方法
EP2561879A1 (en) 2011-08-23 2013-02-27 Protea Biopharma N.V. Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders
US20130065222A1 (en) * 2011-08-30 2013-03-14 Gen-Probe Incorporated Compositions, methods and reaction mixtures for the detection of murine leukemia virus-related virus
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
US20140303025A1 (en) * 2013-03-15 2014-10-09 The Translational Genomics Research Institute Methods for the diagnosis and prognosis of neurodegenerative diseases
KR20170120697A (ko) * 2015-03-10 2017-10-31 가부시키가이샤 시마즈세이사쿠쇼 반응장을 제한한 프로테아제 분해 반응에 의한 항체로부터 펩티드 단편을 얻는 방법
CN114898802B (zh) * 2022-07-14 2022-09-30 臻和(北京)生物科技有限公司 基于血浆游离dna甲基化测序数据的末端序列频率分布特征确定方法、评价方法及装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2120949T4 (es) 1990-06-28 2011-12-29 Sanofi-Aventis Deutschland Gmbh 50% Proteinas de fusión con porciones de inmunoglobulinas, su preparación y empleo.
JP4646315B2 (ja) * 2001-12-07 2011-03-09 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 前立腺癌においてアップレギュレートされた内因性レトロウイルス
CA2603863A1 (en) 2005-04-07 2006-10-19 The Cleveland Clinic Foundation Gammaretrovirus associated with cancer
EP2382326A2 (en) 2008-12-23 2011-11-02 The Cleveland Clinic Foundation Method for detection of xmrv
WO2010148323A2 (en) 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
US20110151431A1 (en) 2009-06-18 2011-06-23 Whittemore Peterson Institute For Neuro-Immune Disease Detection of xenotropic murine leukemia virus
JP2012532190A (ja) 2009-06-30 2012-12-13 アボット ラボラトリーズ Ｘｍｒｖ感染のマーカーとその使用

Similar Documents

Publication Publication Date Title
JP2008538494A5 (https=)
Yoo et al. Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers
Yu et al. Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration
JP5901046B2 (ja) ＯＡＴＰ１Ｂ３ｍＲＮＡの新規な選択的スプライシングバリアント
EP3202914B1 (en) Method for treating a neurodegenerative disease
CN103468813B (zh) Eml4-alk融合基因荧光定量pcr检测试剂盒
JP2007506426A5 (https=)
JP2012526554A5 (https=)
Kano et al. The presence, persistence and functional properties of Plasmodium vivax duffy binding protein II antibodies are influenced by HLA class II allelic variants
RU2012148125A (ru) Биомаркеры на основе мультиракового ассоциированного с инвазией механизма
JP2006500949A5 (https=)
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
AU2009240021A1 (en) Antiviral therapy
JP2012512389A5 (https=)
Zhang et al. Genotyping of–765G> C in COX-2 gene based on MNPs and dual-color fluorescence hybridization and its association with risk of gastric cancer in northern Jiangsu of China
JP2008512984A5 (https=)
JP2015524656A (ja) Ｃｄｋ阻害剤と関連するバイオマーカー
CN106544342A (zh) Mt2a基因组蛋白乙酰化修饰检测试剂盒及引物对
JP2010502192A5 (https=)
KR101997320B1 (ko) 항암 치료 내성 판단 방법 및 상기 방법에 사용되는 조성물
CN114875144B (zh) 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
CN111304311A (zh) 一种用于检测abo血型系统中o基因突变的snp标记
WO2019173712A1 (en) Addressing treatments for glioblastoma
Zhang et al. Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma
CN109402256B (zh) 利用多个免疫调控点分子的表达量评价胶质瘤临床预后的系统